Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Carotid Revascularization Versus Best Medical Treatment for Asymptomatic Carotid Stenosis: a Multicenter, Open, Randomized Controlled Trial in Chinese Population

NCT05623904 is registered in ClinicalTrials.gov with Xuanwu Hospital, Beijing as lead sponsor.

NCT NCT05623904
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05623904 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Carotid Revascularization Versus Best Medical Treatment for Asymptomatic Carotid Stenosis: a Multicenter, Open, Randomized Controlled Trial in Chinese Population
Lead sponsor
Xuanwu Hospital, Beijing
Phase
Not applicable
Overall status
Unknown status
Start date
October 14, 2022
Completion date
December 31, 2025
Enrollment
1,056 (estimated)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

best medical treatment, carotid artery stenosis asymptomatic, carotid artery stenting, carotid endarterectomy